Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Trellus Health PLC on Tuesday announced changes to its leadership, as it appointed a new chief executive officer, chief operating officer and chief financial officer.
The White Plains, New York-based digital health platform said Co-Founder Marla Dubinsky is to assume the role of CEO with immediate effect, as former CEO Monique Fayad stands down from the board.
Fayad will offer consultancy services over a six-month handover period. Dubinsky has served as non-executive director since July 2020 and is reducing other commitments to accommodate her new position.
Non-Executive Chair Julian Baines said: ‘Marla's unrivalled expertise and reputation in this market means she is very well-placed to lead Trellus Health as we execute our commercialisation strategy.’
The current US Executive Vice President Sales & Development Aled Stevenson will become COO with immediate effect. Stevenson joined the digital health company a year ago, following a 19-year career at AstraZeneca PLC.
‘It remains our strategy to focus on both a [direct to consumer] model as well as a business-to-business model to expand our customer base,’ said Baines.
Richard Evans who has served as interim CFO will resume his retirement. His role will transition back to Company Secretary & former CFO Salim Hamir. ‘The board is reviewing the needs of the business in terms of the finance function and expects to make a further appointment in due course,’ Trellus said.
Shares in Trellus Health closed down 4.8% at 10.00 pence in London on Tuesday.
Copyright 2022 Alliance News Limited. All Rights Reserved.